BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23380191)

  • 21. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries.
    Oortwijn W; Mathijssen J; Banta D
    Health Policy; 2010 May; 95(2-3):174-84. PubMed ID: 20074829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?
    ; Neumann PJ; Drummond MF; Jönsson B; Luce BR; Schwartz JS; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2010 Jan; 26(1):71-8. PubMed ID: 20059783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health system and equity perspectives in health technology assessment.
    Hanvoravongchai P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Editorial: Pursuing efficiency: a dead end for HTA?
    Jaime Caro J
    Value Health; 2009 Jun; 12 Suppl 2():S49. PubMed ID: 19523185
    [No Abstract]   [Full Text] [Related]  

  • 25. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health technology assessment in Denmark: strategy, implementation, and developments.
    Sigmund H; Kristensen FB
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():94-101. PubMed ID: 19505351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stakeholders involvement by HTA Organisations: why is so different?
    Cavazza M; Jommi C
    Health Policy; 2012 May; 105(2-3):236-45. PubMed ID: 22364715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resource allocation and health technology assessment in Australia: views from the local level.
    Gallego G; van Gool K; Kelleher D
    Int J Technol Assess Health Care; 2009 Apr; 25(2):134-40. PubMed ID: 19331706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health technology assessment in Catalonia: an overview of past and future perspectives.
    de Solà-Morales O; Granados A
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():88-93. PubMed ID: 19519981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health technology assessment: research trends and future priorities in Europe.
    Nielsen CP; Funch TM; Kristensen FB
    J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffusion and use of health technology assessment in policy making: what lessons for decentralised healthcare systems?
    Ciani O; Tarricone R; Torbica A
    Health Policy; 2012 Dec; 108(2-3):194-202. PubMed ID: 23093020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Office of Technology Assessment health program.
    Banta D; Behney CJ
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():28-32. PubMed ID: 19519980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic evaluation for pharmaceuticals in Germany.
    Jönsson B
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S1-2. PubMed ID: 17638033
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experiences with and impact of health technology assessment on the German Standing Committee of physicians and patients].
    Gibis B; Rheinberger P
    Z Arztl Fortbild Qualitatssich; 2002 Feb; 96(2):82-90. PubMed ID: 11921610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Policy making and roles of health technology assessment.
    Tantivess S
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S88-99. PubMed ID: 19253491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technology assessment in the German context.
    Drummond M
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S3. PubMed ID: 17619919
    [No Abstract]   [Full Text] [Related]  

  • 37. IQWiG methods--a response to two critiques.
    Caro JJ; Nord E; Siebert U; McGuire A; McGregor M; Henry D; de Pouvourville G; Atella V; Kolominsky-Rabas P
    Health Econ; 2010 Oct; 19(10):1137-8. PubMed ID: 20842681
    [No Abstract]   [Full Text] [Related]  

  • 38. Review of medical technology policies shows need, opportunities for changes.
    Banta D
    Hospitals; 1982 Apr; 56(7):87-90. PubMed ID: 6800914
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost-effectiveness analysis and innovation.
    Jena AB; Philipson TJ
    J Health Econ; 2008 Sep; 27(5):1224-36. PubMed ID: 18619695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. History of health technology assessment: Spain.
    Sampietro-Colom L; Asua J; Briones E; Gol J;
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():163-73. PubMed ID: 19538814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.